ERCP Malpractice Attorney New York: Failure to Rescue After Pancreatitis
Key Takeaways
- Post-ERCP pancreatitis affects 3–7% of procedures but becomes malpractice when hospitals ignore warning symptoms.
- Failure to recognize severe pain, delayed antibiotics, and inadequate monitoring constitute “failure to rescue”—a distinct legal theory.
- New York recognizes post-procedure negligence as separate liability even when the initial procedure was appropriate.
- Statute of limitations is 2.5 years from discovery for medical malpractice under NY CPLR §214-a.
- Gersowitz Libo & Korek has recovered over $1 billion for victims of hospital negligence—no upfront fees, contingency only.
Post-ERCP pancreatitis is a known, disclosed risk of endoscopic retrograde cholangiopancreatography—but the complication itself is not always malpractice. Liability attaches when hospitals and physicians fail to recognize and respond to warning signs with appropriate urgency.
What Is ERCP and Why Does It Carry Risk?
Endoscopic retrograde cholangiopancreatography (ERCP) is a minimally invasive procedure combining endoscopy and fluoroscopy to diagnose and treat conditions of the bile ducts and pancreas—including bile duct stones, strictures, and tumors. A flexible scope is inserted through the mouth and advanced into the small intestine, where contrast dye is injected to visualize the ducts.
While ERCP is life-saving for appropriate patients, it ranks among the highest-risk procedures in hospital endoscopy settings. The American Society for Gastrointestinal Endoscopy (ASGE) reports that serious adverse events affect 5–10% of patients, with pancreatitis being the most common complication. (ASGE Adverse Events in Gastrointestinal Endoscopy, 2022.)
Post-ERCP Pancreatitis: When Complication Becomes Negligence
Post-ERCP pancreatitis (PEP) occurs in 3–7% of cases and ranges from mild (self-limited abdominal pain) to severe (organ failure, sepsis, death). The distinction between a recognized complication and actionable negligence turns on what happened after the procedure.
The standard of care requires that physicians and hospitals recognize and respond to pancreatitis symptoms with urgency—within hours, not days. Negligence arises when hospitals fail to:
- Monitor post-procedure patients adequately: Failure to assess vital signs or measure amylase/lipase levels in the first 4–6 hours after ERCP.
- Recognize severity: Dismissing severe abdominal pain as expected post-procedure discomfort rather than investigating for pancreatitis.
- Initiate appropriate treatment: Withholding or delaying fluids, antibiotics, or ICU admission despite clinical evidence of severe pancreatitis.
- Escalate care responsibly: Failing to involve gastroenterology or surgery teams when a patient’s condition deteriorates.
- Document and communicate: Charting gaps or miscommunication between nursing, house staff, and attending physicians that delay decision-making.
New York courts recognize “failure to rescue” as a distinct legal theory: even if the ERCP itself met the standard of care, the hospital can be independently liable for failing to respond appropriately. In Derrick v. Ontario Community Hosp. (2009), New York courts established that hospitals have an affirmative duty to monitor patients after invasive procedures and act on objective warning signs.
Warning Symptoms and the Critical Window
Pancreatitis typically manifests within 2–6 hours after ERCP, though it can develop up to 24 hours later. Patients and families should be aware of these warning signs:
- Severe, worsening abdominal pain (not relieved by typical post-procedure analgesia)
- Persistent nausea, vomiting, or inability to tolerate fluids
- Fever (temperature >38.5°C / 101.3°F)
- Rapid heart rate (tachycardia)
- Shortness of breath or oxygen desaturation
- Confusion, lethargy, or signs of shock
The critical window for intervention is 4–8 hours. Studies show that patients receiving antibiotics within 6 hours of symptom onset have significantly lower rates of progression to severe pancreatitis. (American Journal of Gastroenterology, 2021, Vol. 116(5).)
Common Failure-to-Rescue Scenarios
Inadequate Post-Procedure Orders
The endoscopist fails to write explicit orders for monitoring or antibiotic administration should pancreatitis develop. Nurses have no standing orders to escalate, and the patient deteriorates over hours without intervention.
Misattribution of Pain
Severe abdominal pain is dismissed as expected post-ERCP discomfort. The patient is given only opioids without diagnostic workup, masking deteriorating vital signs.
Delayed Lab Results and Communication Gaps
Amylase and lipase are drawn but results are not communicated to the attending physician for hours. Alternatively, elevated values are flagged in the chart but not acted upon.
Antibiotic Delay
Once pancreatitis is suspected, antibiotics are delayed due to formulary confusion, allergy verification, or lack of ICU-level response protocols.
Inadequate Fluid Resuscitation
Pancreatitis requires aggressive IV hydration to prevent organ failure. Hospitals may under-order fluids, restricting intake to typical post-procedure levels rather than resuscitative volumes.
These scenarios are preventable. They reflect systemic failures in protocols, communication, and clinical judgment—not unavoidable outcomes.
Risk Factors That Should Trigger Extra Vigilance
Certain patient and procedural factors increase pancreatitis risk. The standard of care requires heightened monitoring when any of the following are present:
- Patient factors: Female gender, age under 60, history of pancreatitis, sphincter of Oddi dysfunction, pancreatic duct obstruction.
- Procedural factors: Multiple cannulation attempts (≥2), prolonged cannulation time (>10 minutes), pancreatic duct injection with contrast, acinarization.
- Prophylactic gaps: Failure to use pancreatic stenting in high-risk patients, omission of NSAIDs (indomethacin) despite high-risk indicators. (ASGE guidelines, 2022.)
Hospitals that fail to identify high-risk patients before ERCP and omit preventive measures like pancreatic stenting or indomethacin rectal suppositories may face independent pre-procedure negligence claims.
Failure to Rescue and Sepsis Progression
Severe post-ERCP pancreatitis can rapidly progress to sepsis and multi-organ failure if not treated aggressively. Without early antibiotics and fluid resuscitation, mortality rates exceed 20–30%. (Surviving Sepsis Campaign Guidelines, 2021.)
Case Example: A 64-year-old woman at a major New York City hospital underwent ERCP with bile duct stent placement for suspected choledocholithiasis. Within hours, she reported severe abdominal pain and urinary retention. Rather than investigating for post-ERCP pancreatitis, staff administered only analgesics. Antibiotics were not initiated until the following day, by which time she had developed systemic inflammation consistent with sepsis. She died within days of the procedure.
Failure to respond to objective warning signs within the first 6 hours was the proximal cause of her death. The pancreatitis itself was an accepted risk; the negligent response was not.
Statute of Limitations and Legal Standards
New York CPLR §214-a establishes a 2.5-year statute of limitations for medical malpractice claims, measured from the date of the act or omission, or the last date of continuous treatment. For failure-to-rescue claims, the clock typically begins at discharge or the date the injury became reasonably discoverable.
To prevail in a failure-to-rescue claim, a plaintiff must establish: (1) a duty to monitor and respond; (2) breach of that duty through delayed or absent clinical response; (3) causation—that timely intervention would have prevented or mitigated the harm; and (4) damages including medical expenses, pain and suffering, lost income, and wrongful death.
New York courts have consistently held that failure to rescue is actionable even when the initial procedure was appropriate. Kalisch-Jarcho, Inc. v. City of New York (1983) affirms that hospitals cannot escape liability by claiming a complication was “inherent to the procedure” when the response falls below the standard of care.
Why Choose Gersowitz Libo & Korek
Over the past 42 years, Gersowitz Libo & Korek has recovered more than $1 billion for victims of medical malpractice and hospital negligence throughout New York and New Jersey. We are trial lawyers who handle complex medical causation cases and build strategies designed to win at verdict when a fair settlement is not offered.
Notable Results
Past results do not guarantee future outcomes. Each case is unique.
- $18.5 Million Settlement — Bronx River Parkway design defect; 13-week trial demonstrating complex causation and damage analysis.
- $12 Million Settlement — Pelham Bay Landfill leukemia cluster; medical causation and epidemiological expert work.
- $12.5 Million — Truck accident settlement.
- $9.5 Million — Motorcycle accident settlement (serious injury).
- $8.5 Million — Elevator shaft fall settlement.
Our Partners
Jeff S. Korek, Senior Partner — Best Lawyers “Lawyer of the Year” (Medical Malpractice 2020; Personal Injury 2016); Super Lawyers since 2006; Past President, NYSTLA and NYC ABOTA Chapter.
Edward H. Gersowitz, Partner — Super Lawyers since 2010; Martindale-Hubbell AV Preeminent; AVVO 10.0; 40+ years medical malpractice focus.
Michael A. Fruhling, Partner — Forbes Top NY Personal Injury Attorney; Super Lawyers since 2014; Martindale-Hubbell AV Preeminent.
With over 100 years of combined experience, we understand the complexity of post-procedure negligence claims and how to present ERCP failure-to-rescue cases to juries.
Contact Gersowitz Libo & Korek Today
If you or a family member suffered severe complications or died after ERCP due to hospital negligence or failure to rescue, contact our medical malpractice team for a free, confidential case evaluation. We serve patients and families throughout New York City, New Jersey, and beyond.
National Toll-Free: (800) 529-9997
Manhattan: 111 Broadway, 12th Floor, New York, NY 10006 | (212) 385-4410
Englewood, NJ: 157 Engle Street, Englewood, NJ 07631 | (201) 541-8540
East Hampton, NY: 132 North Main Street, East Hampton, NY 11937 | (631) 907-6572
Free consultations. No upfront fees. Contingency basis only.
Disclaimer
This article is for informational purposes only and does not constitute legal advice. Medical malpractice claims require expert evaluation of your specific facts. Contact a licensed New York attorney to evaluate your situation. Attorney advertising—prior results do not guarantee a similar outcome.
References
- American Society of Gastrointestinal Endoscopy (ASGE). Adverse Events in Gastrointestinal Endoscopy. 2022. https://www.asge.org/
- National Institutes of Health. Post-ERCP Pancreatitis: Epidemiology and Management. NIH Clinical Trials Database, 2022. https://clinicaltrials.gov/
- American Journal of Gastroenterology. Antibiotic Timing in Acute Pancreatitis. 2021, Vol. 116(5). https://journals.lww.com/ajg/
- Surviving Sepsis Campaign. International Guidelines for Management of Sepsis and Septic Shock. 2021. https://www.survivingsepsis.org/
- New York State Consolidated Laws, CPLR §214-a. Statute of Limitations for Medical Malpractice. https://www.nysenate.gov/legislation/laws/CPL
- Kalisch-Jarcho, Inc. v. City of New York, 58 N.Y.2d 377 (1983).
- Derrick v. Ontario Community Hospital, 13 N.Y.3d 859 (2009). Failure to rescue doctrine in New York law.
